NASDAQ:AUTL

Autolus Therapeutics Stock Predictions

etoro logo Buy AUTL
*Your capital is at risk
$1.62
-0.130 (-7.43%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AUTL Prediction Chart

AUTL Predictions History

Latest community submissions for AUTL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 27, 2025 Bullish $2.26 X 0
Dec 17, 2024 $2.64 +2.26% $2.49 X 94.05% 0
Dec 17, 2024 $2.67 +3.61% $2.49 X 92.64% 0
gregornimrod gregornimrod Merchant
Dec 17, 2024 Bullish $2.49 X 0
JS JS Pro
Dec 22, 2023 $5.59 -0.89% $5.68 X 98.42% 0
Dec 22, 2023 $5.55 -1.67% $5.68 X 97.64% 0
Dec 22, 2023 $5.49 -2.67% $5.68 X 96.64% 0
Mar 15, 2023 $2.05 -2.48% $2.09 V 97.98% 1
Mar 15, 2023 $2.07 -1.55% $2.09 V 98.92% 2
Mar 15, 2023 Bullish $2.09 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AUTL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AUTOLUS THERAPEUTICS PLC
Autolus Therapeutics
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a program...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE